Mohammad A. Rafi

3.6k total citations
66 papers, 2.6k citations indexed

About

Mohammad A. Rafi is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Mohammad A. Rafi has authored 66 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Physiology, 27 papers in Molecular Biology and 20 papers in Epidemiology. Recurrent topics in Mohammad A. Rafi's work include Lysosomal Storage Disorders Research (41 papers), Trypanosoma species research and implications (15 papers) and Cellular transport and secretion (12 papers). Mohammad A. Rafi is often cited by papers focused on Lysosomal Storage Disorders Research (41 papers), Trypanosoma species research and implications (15 papers) and Cellular transport and secretion (12 papers). Mohammad A. Rafi collaborates with scholars based in United States, Iran and Italy. Mohammad A. Rafi's co-authors include David A. Wenger, Paola Luzi, Yadollah Omidi, Mohammad M. Pourseif, Han Zhi Rao, Jaleh Barar, Mark Curtis, Elvira Costantino‐Ceccarini, Jafar Razmara and Sepideh Parvizpour and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Mohammad A. Rafi

65 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad A. Rafi United States 30 1.4k 1.2k 557 491 255 66 2.6k
Michel Jadot Belgium 25 958 0.7× 1.5k 1.2× 380 0.7× 906 1.8× 250 1.0× 75 2.8k
Eric Ka‐Wai Hui United States 34 513 0.4× 1.1k 0.9× 610 1.1× 226 0.5× 73 0.3× 66 2.5k
Andreas Weihofen United States 20 685 0.5× 1.5k 1.2× 580 1.0× 483 1.0× 78 0.3× 31 3.1k
O. P. van Diggelen Netherlands 30 2.6k 1.9× 1.1k 0.9× 1.0k 1.9× 650 1.3× 786 3.1× 87 3.6k
Jeff Zhiqiang Lu United States 32 479 0.3× 838 0.7× 309 0.6× 189 0.4× 89 0.3× 53 2.0k
Marjan van Meurs Netherlands 30 866 0.6× 880 0.7× 347 0.6× 343 0.7× 138 0.5× 64 3.3k
David L. Marks United States 37 1.4k 1.0× 2.7k 2.2× 254 0.5× 2.0k 4.0× 298 1.2× 69 4.4k
Yoram Altschuler Israel 32 505 0.4× 2.8k 2.3× 655 1.2× 1.7k 3.4× 75 0.3× 47 5.1k
A. T. Hoogeveen Netherlands 29 848 0.6× 1.9k 1.5× 201 0.4× 399 0.8× 210 0.8× 80 3.0k
H. Galjaard Netherlands 42 2.1k 1.5× 2.6k 2.2× 543 1.0× 985 2.0× 626 2.5× 138 5.3k

Countries citing papers authored by Mohammad A. Rafi

Since Specialization
Citations

This map shows the geographic impact of Mohammad A. Rafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad A. Rafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad A. Rafi more than expected).

Fields of papers citing papers by Mohammad A. Rafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad A. Rafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad A. Rafi. The network helps show where Mohammad A. Rafi may publish in the future.

Co-authorship network of co-authors of Mohammad A. Rafi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad A. Rafi. A scholar is included among the top collaborators of Mohammad A. Rafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad A. Rafi. Mohammad A. Rafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Esmaeili, Abolghasem, et al.. (2020). Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumours. Journal of drug targeting. 28(7-8). 700–713. 23 indexed citations
2.
Safary, Azam, Mostafa Akbarzadeh-Khiavi, Yadollah Omidi, & Mohammad A. Rafi. (2019). Targeted enzyme delivery systems in lysosomal disorders: an innovative form of therapy for mucopolysaccharidosis. Cellular and Molecular Life Sciences. 76(17). 3363–3381. 16 indexed citations
3.
Barar, Jaleh, Mohammad A. Rafi, Mohammad M. Pourseif, & Yadollah Omidi. (2016). Blood-brain barrier transport machineries and targeted therapy of brain diseases. Bioimpacts. 6(4). 225–248. 177 indexed citations
4.
Lee, Kunwoo, Mohammad A. Rafi, Xiaojian Wang, et al.. (2015). In vivo delivery of transcription factors with multifunctional oligonucleotides. Nature Materials. 14(7). 701–706. 58 indexed citations
5.
Rafi, Mohammad A. & Yadollah Omidi. (2015). A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination. Bioimpacts. 5(3). 117–122. 17 indexed citations
6.
Ning, Xinghai, Seungjun Lee, Kiyoko Takemiya, et al.. (2014). PET Imaging of Bacterial Infections with Fluorine‐18‐Labeled Maltohexaose. Angewandte Chemie International Edition. 53(51). 14096–14101. 111 indexed citations
7.
Rafi, Mohammad A., Han Zhi Rao, Paola Luzi, Mark Curtis, & David A. Wenger. (2012). Extended Normal Life After AAVrh10-mediated Gene Therapy in the Mouse Model of Krabbe Disease. Molecular Therapy. 20(11). 2031–2042. 82 indexed citations
8.
Luzi, Paola, Ronnie M. Abraham, Mohammad A. Rafi, et al.. (2009). Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy. Brain Research. 1300. 146–158. 60 indexed citations
9.
Cheng, Xiaodong, Muḥammad Mukhtār, Edward Acheampong, et al.. (2007). HIV-1 Vpr Potently Induces Programmed Cell Death in the CNS in Vivo. DNA and Cell Biology. 26(2). 116–131. 20 indexed citations
10.
Lissens, Willy, Sara Seneca, Mohammad A. Rafi, et al.. (2007). A single mutation in the GALC gene is responsible for the majority of late onset Krabbe disease patients in the Catania (Sicily, Italy) region. Human Mutation. 28(7). 742–742. 36 indexed citations
12.
Wenger, David A., et al.. (2000). Krabbe Disease: Genetic Aspects and Progress toward Therapy. Molecular Genetics and Metabolism. 70(1). 1–9. 157 indexed citations
13.
Vanier, M. T., Gilles Millat, Christophe Marçais, et al.. (1999). Niemann-Pick C disease : insight from studies on mutated NPC1 gene and protein. 15(2). 120. 1 indexed citations
14.
Costantino‐Ceccarini, Elvira, et al.. (1999). Transduction of Cultured Oligodendrocytes from Normal and Twitcher Mice by a Retroviral Vector Containing Human Galactocerebrosidase (GALC) cDNA. Neurochemical Research. 24(2). 287–293. 21 indexed citations
15.
Giugliani, Roberto, et al.. (1999). Protracted Course of Krabbe Disease in an Adult Patient Bearing a Novel Mutation. Archives of Neurology. 56(8). 1014–1014. 21 indexed citations
16.
Luzi, Paola, Teresa Victoria, Mohammad A. Rafi, & David A. Wenger. (1997). Analysis of the 5′ Flanking Region of the Human Galactocerebrosidase (GALC) Gene. Biochemical and Molecular Medicine. 62(2). 159–164. 9 indexed citations
17.
Rafi, Mohammad A., et al.. (1996). Retroviral Vector-Mediated Transfer of the Galactocerebrosidase (GALC) cDNA Leads to Overexpression and Transfer of GALC Activity to Neighboring Cells. Biochemical and Molecular Medicine. 58(2). 142–150. 38 indexed citations
18.
Luzi, Paola, Mohammad A. Rafi, & David A. Wenger. (1995). Structure and organization of the human galactocerebrosidase (GALC) gene. Genomics. 26(2). 407–409. 71 indexed citations
19.
Chakraborty, Supriya, Mohammad A. Rafi, & David A. Wenger. (1994). Mutations in the lysosomal beta-galactosidase gene that cause the adult form of GM1 gangliosidosis.. PubMed. 54(6). 1004–13. 28 indexed citations
20.
Rafi, Mohammad A., et al.. (1993). Cloning and expression cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy. Human Molecular Genetics. 2(11). 1841–1846. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026